![Lorianne Masuoka](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Lorianne K.
Masuoka worked as Senior Associate Director-Clinical Development at Bayer Schering Pharma AG and Berlex Laboratories, Inc. from 1994 to 2000.
From 2000 to 2003, served as Oncology Director at Chiron Corp.
Held the position of Vice President-Clinical Development at Five Prime Therapeutics, Inc. between 2003 and 2008.
Occupied the role of Chief Medical Officer & Senior Vice President at Nektar Therapeutics from 2009 to 2011.
Served as Chief Medical Officer at Cubist Pharmaceuticals LLC from 2013 to 2015, Invivo Therapeutics Holdings Corp.
from 2015 to 2017, Immedica Pharma US, Inc. from 2017 to 2019, Epygenix Therapeutics, Inc. from 2022 to 2023, and DiaMedica Therapeutics, Inc. from 2024 to 2025.
Held Independent Director roles at The Pelican, Inc. from 2019 to 2020 and Opiant Pharmaceuticals, Inc. from 2021 to 2023.
Education includes undergraduate and doctorate degrees from the University of California, Davis.
Antiguos cargos conocidos de Lorianne Masuoka.
| Empresas | Cargo | Fin |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Director Técnico/Científico/I+D | 04/08/2025 |
Epygenix Therapeutics, Inc.
 Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Director Técnico/Científico/I+D | 01/12/2023 |
| OPIANT PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 02/03/2023 |
| PFENEX INC. | Director/Miembro de la Junta | 01/10/2020 |
| MARINUS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 31/10/2019 |
Formación de Lorianne Masuoka.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
55
Relaciones de 1er grado
13
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 13 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Bayer Schering Pharma AG
 Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for addictions and drug overdose | Health Technology |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Invivo Therapeutics Holdings Corp.
 Invivo Therapeutics Holdings Corp. BiotechnologyHealth Technology Develops technologies for the treatment of spinal cord injuries | Health Technology |
Berlex Laboratories, Inc. | Health Technology |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
- Bolsa de valores
- Insiders
- Lorianne Masuoka
